134 related articles for article (PubMed ID: 34453500)
1. No developmental toxicity observed with dolutegravir in rat whole embryo culture.
Posobiec LM; Chapman SP; Murzyn SF; Rendemonti JE; Stanislaus DJ; Romach EH
Birth Defects Res; 2021 Oct; 113(16):1190-1197. PubMed ID: 34453500
[TBL] [Abstract][Full Text] [Related]
2. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels.
Mohan H; Lenis MG; Laurette EY; Tejada O; Sanghvi T; Leung KY; Cahill LS; Sled JG; Delgado-Olguín P; Greene NDE; Copp AJ; Serghides L
EBioMedicine; 2021 Jan; 63():103167. PubMed ID: 33341441
[TBL] [Abstract][Full Text] [Related]
3. Dolutegravir-induced neural tube defects in mice are folate responsive.
Tukeman GL; Wei H; Lin YL; Wlodarczyk BJ; Finnell RH; Cabrera RM
AIDS; 2024 Mar; 38(4):439-446. PubMed ID: 37382903
[TBL] [Abstract][Full Text] [Related]
4. The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid.
Cabrera RM; Souder JP; Steele JW; Yeo L; Tukeman G; Gorelick DA; Finnell RH
AIDS; 2019 Nov; 33(13):1967-1976. PubMed ID: 31259764
[TBL] [Abstract][Full Text] [Related]
5. Absence of developmental and reproductive toxicity in animals exposed to dolutegravir.
Stanislaus DJ; Posobiec LM; Laffan SB; Solomon HM; Ziejewski MK; Romach EH
Birth Defects Res; 2020 Feb; 112(3):245-261. PubMed ID: 31859466
[TBL] [Abstract][Full Text] [Related]
6. Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment.
Bade AN; McMillan JM; Liu Y; Edagwa BJ; Gendelman HE
Mol Neurobiol; 2021 Nov; 58(11):5703-5721. PubMed ID: 34390469
[TBL] [Abstract][Full Text] [Related]
7. Dolutegravir Impairs Stem Cell-Based 3D Morphogenesis Models in a Manner Dependent on Dose and Timing of Exposure: An Implication for Its Developmental Toxicity.
Kirkwood-Johnson L; Katayama N; Marikawa Y
Toxicol Sci; 2021 Nov; 184(2):191-203. PubMed ID: 34515794
[TBL] [Abstract][Full Text] [Related]
8. Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta.
Gilmore JC; Hoque MT; Dai W; Mohan H; Dunk C; Serghides L; Bendayan R
EBioMedicine; 2022 Jan; 75():103771. PubMed ID: 34954655
[TBL] [Abstract][Full Text] [Related]
9. Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Kreitchmann R; Oliveira FR; Sprinz E
Braz J Infect Dis; 2021; 25(2):101572. PubMed ID: 33852885
[TBL] [Abstract][Full Text] [Related]
10. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.
Dugdale CM; Ciaranello AL; Bekker LG; Stern ME; Myer L; Wood R; Sax PE; Abrams EJ; Freedberg KA; Walensky RP
Ann Intern Med; 2019 May; 170(9):614-625. PubMed ID: 30934067
[TBL] [Abstract][Full Text] [Related]
11. Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.
Pereira GFM; Kim A; Jalil EM; Fernandes Fonseca F; Shepherd BE; Veloso VG; Rick F; Ribeiro R; Pimenta MC; Beber A; Corrêa RG; Lima R; Maruri F; McGowan CC; Schwartz Benzaken A; Grinsztejn B; Castilho JL;
Lancet HIV; 2021 Jan; 8(1):e33-e41. PubMed ID: 33387477
[TBL] [Abstract][Full Text] [Related]
12. Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity.
Anstett K; Fusco R; Cutillas V; Mesplède T; Wainberg MA
J Virol; 2015 Oct; 89(20):10482-8. PubMed ID: 26246578
[TBL] [Abstract][Full Text] [Related]
13. Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
Waitt C; Orrell C; Walimbwa S; Singh Y; Kintu K; Simmons B; Kaboggoza J; Sihlangu M; Coombs JA; Malaba T; Byamugisha J; Amara A; Gini J; Else L; Heiburg C; Hodel EM; Reynolds H; Mehta U; Byakika-Kibwika P; Hill A; Myer L; Lamorde M; Khoo S
PLoS Med; 2019 Sep; 16(9):e1002895. PubMed ID: 31539371
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and placental transfer of dolutegravir in pregnancy.
Ikumi NM; Anumba D; Matjila M
J Antimicrob Chemother; 2022 Feb; 77(2):283-289. PubMed ID: 34618029
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of heparin in postimplantation whole-embryo culture.
Kesby GJ
Toxicol Appl Pharmacol; 2000 Feb; 163(1):60-6. PubMed ID: 10662605
[TBL] [Abstract][Full Text] [Related]
16. Effect of prednisone on the pharmacokinetics of the integrase inhibitor dolutegravir.
Song IH; Borland J; Chen S; Savina P; Peppercorn AF; Piscitelli S
Antimicrob Agents Chemother; 2013 Sep; 57(9):4394-7. PubMed ID: 23817375
[TBL] [Abstract][Full Text] [Related]
17. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
[TBL] [Abstract][Full Text] [Related]
18. Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model.
Mohan H; Nguyen J; MacKenzie B; Yee A; Laurette EY; Sanghvi T; Tejada O; Dontsova V; Leung KY; Goddard C; De Young T; Sled JG; Greene NDE; Copp AJ; Serghides L
EBioMedicine; 2023 Sep; 95():104762. PubMed ID: 37586112
[TBL] [Abstract][Full Text] [Related]
19. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.
Rimawi BH; Johnson E; Rajakumar A; Tao S; Jiang Y; Gillespie S; Schinazi RF; Mirochnick M; Badell ML; Chakraborty R
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
